par Weets, Ilse;Siraux, Valérie;Daubresse, Jean-Claude
;De Leeuw, Ivo;Fery, Françoise
;Keymeulen, Bart;Krzentowski, Georges;Letiexhe, Michel;Mathieu, Chantal;Nobels, Frank;Rottiers, Raoul;Scheen, André;Van Gaal, Luc;Schuit, Frans;Van Der Auwera, Bart;Rui, Mao;De Pauw, Pieter;Kaufman, Leonard;Gorus, Frans
Référence The Journal of clinical endocrinology and metabolism, 87, 6, page (2597-2605)
Publication Publié, 2002


Référence The Journal of clinical endocrinology and metabolism, 87, 6, page (2597-2605)
Publication Publié, 2002
Article révisé par les pairs
Résumé : | We investigated inaugural disease phenotype in relation to the presence or absence of diabetes-associated autoantibodies and human leukocyte antigen (HLA) DQ risk genotypes in adult-onset diabetic patients. Blood samples and questionnaires were obtained from 1584 recent-onset Belgian Caucasian patients (age 15-39 yr at diagnosis of primary diabetes) who were recruited by the Belgian Diabetes Registry over an 11-yr period. At clinical diagnosis, antibody-positive patients (n = 1198) were on average younger and had more symptoms, a more acute disease onset, lower body mass index, and random C-peptide levels, but higher insulin needs, glycemia, and prevalence of ketonuria, HLA-DQ, and 5′ insulin gene susceptibility genotypes (P < 0.001 vs. antibody-negative patients; n = 386). In antibody-positive patients, these characteristics did not differ according to HLA-DQ genotype. However, in antibody-negative subjects, we found that patients were younger (P = 0.001); had a lower body mass index (P < 0.001), higher insulin needs (P = 0.014), and amylasemia (P = 0.001); and tended to have a higher glycemia and lower C-peptide in the presence of susceptible HLA-DQ genotypes. Differences according to HLA-DQ genotype subsisted after careful age-matching. In conclusion, we found no relation between initial disease phenotype and HLA-DQ genotype in antibody-positive diabetic young adults. In contrast, antibody-negative patients displayed more type 1-like features when carrying susceptible HLA-DQ genotypes known to promote the development of antibody-positive diabetes. The overrepresentation of these susceptibility genotypes in antibody-negative patients suggests the existence of an immune-mediated disease process with as yet unidentified immune markers in a subgroup of seronegative patients. |